FDA Investigator Carl A Anderson

Carl A Anderson has conducted inspections on 111 sites in 8 countries as of 06 Dec 2004. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
111
Last Inspection Date:
06 Dec 2004
Investigator Role:
FDA Investigation Participant
Redica ID:
100003339
Countries of Inspections:
United States of America, Sweden, France, United Kingdom of Great Britain and Northern Ireland, Switzerland, Ireland, Canada, Italy
FDA Investigators that have inspected at least one site in common with Carl A Anderson:
Alan D Grupe, Alexander M Kay, Anastasia G Lolas, Anastasia M Shields, Andrew R Wasko, Anita Narula, PhD, Ann Marie Montemurro, Ashleigh P Barkans, Astrida B Mattson, Azza Talaat, Barbara Janine Breithaupt, Bonnie E Conley, Bonnie E Pierson, Brandon C Heitmeier, Brenda K Alford, Brenda L Reihing, Carol A Gripp, Catherine J Laufmann, Charisse K Green, Charles I Ann, Charles M Edwards, Charles R Bonapace, PhD, Christine W Twohy, Christopher R Czajka, Connie P Rezendes, Ct Viswanathan, PhD, Cynthia J Lee, MS, Cynthia L Gorveatt, Darla J Christopher, David J Gomes, Dawn E Barkans, Deborah A Nebenzahl, Dennis G Kawabata, Dennis R Hudson, Deyaa Shaheen, Dolores E Price, Donald B Mckechnie, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Edward D Harris, Edward D Mcdonald, Edward Deberry, Elizabeth Ll Edwards, Elizabeth S Howell, Eric S Weilage, Erika V Butler, Erin M Mcdowell, Gayle S Lawson, Gerard Pde Leon, Gloria J Baca, MS, Gordon T Wales, Grace P Santos, Gwyn G Dickinson, Heika R Bounds, Heika R Tait, Helen B Ricalde, Hugh A Grimoldby, Hugh M Mcclure, II, Jacqueline A O'shaughnessy, PhD, James A Jagon, James A Lane, James C Henry, Jane M Kreis, Jennifer D Hollstrom, Joey V Quitania, Jonathan T Little, Jose Acruz Gonzalez, Jose M Cayuela, Julian C Hanson, Julie D Bringger, Karen L Kosar, Katherine E Jacobitz, Kathryn A Krentz, Kent C Faul, Kevin D Kallander, Kim Lthomas Cruse, Larry K Austin, Laurie B Frazier, Lawrence Y Lee, PhD, Linda S Leja, Lisa K Capron, Lori J Silverstein, Lorna F Jones, Marcelo O Mangalindan, Jr, Maria Pkelly Doggett, MBA, Marie F Morin, Marijo B Kambere, PhD, Mark W Babbitt, Matthew R Dionne, Maxwell Van Tassell, PhD, Maya M Davis, Michael F Skelly, PhD, Michael J Lackey, Michael J Nerz, Michael L Casner, Mihaly S Ligmond, Minh D Phan, Mra Davism, Mra Mcculloughj, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy G Schmidt, Nancy M Espinal, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Paul A Bonneau, Paul F Rader, Peter C Chow, Peter Kessler, PhD, Peter R Lenahan, Prabhu P Raju, Ramesh Potla, PhD, Randy L Self, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Robert A Williams, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Robert M Tillman, Rocco C Black, Russell K Riley, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Scott A Nabe, Sharon I Gundersen, Sharon K Thoma, PharmD, Sherri N Rohlf, MD, Sidney B Priesmeyer, Stanley B Eugene, BS, BME, Stephen D Brown, Stephen R Souza, Steven D Kehoe, Stuart W Russell, Sue Lee Chan, Sunitha K Rajaram, PhD, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Terri L Dodds, Thomas E Friel, Timothy T Kapsala, Tracy K Li, Truong Xuan Nguyen (Andy), V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica L Bush, William V Millar, Xiaojun Yan, Yanming An, PhD, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Zhong Li, PhD

Carl A Anderson's Documents

Publish Date Document Type Title
November, 2003 FDA 483 Biodevelopment Associates, Llc - Form 483, 2003-11-13
March, 2002 EIR Peter D. Londborg, MD dba Seattle Clinical Research Center - EIR, 2002-03-14
June, 2002 FDA 483 Wallace O'Farrell Marketing, Inc. - Form 483, 2002-06-24
February, 2002 FDA 483 Response Forest Laboratories Ireland Limited - Form 483R, 2002-03-25
July, 2002 FDA 483 B & C Laboratories Inc - Form 483, 2002-07-18
March, 2000 FDA 483 Botanical Laboratories Inc - Form 483, 2000-03-10
February, 2001 EIR MDS Pharma Services - EIR, 2001-02-05
September, 2003 EIR Swedish Orphan Biovitrum International AB - EIR, 2003-10-24
September, 2000 FDA 483 Response Arifulla Khan MD - Form 483R, 2000-09-18
May, 2002 FDA 483 Integra Chemical Company - Form 483, 2002-05-21
August, 2002 FDA 483 Western Institutional Review Board, Inc. - Form 483, 2002-08-23
February, 2001 FDA 483 MDS Pharma Services - Form 483, 2001-02-05
May, 2002 FDA 483 Response Integra Chemical Company - Form 483R, 2002-06-25
October, 2000 FDA 483 Airgas USA, LLC - Form 483, 2000-10-30
November, 2002 EIR Anna Wald, MD - EIR, 2002-11-15
February, 2002 FDA 483 Sanofi-Synthelabo - Form 483, 2002-02-21
September, 2002 EIR WCG IRB, Inc - EIR, 2002-09-27
April, 2002 FDA 483 CTI Biopharma Corp - Form 483, 2002-04-05
May, 2002 EIR Integra Chemical Company - EIR, 2002-05-21
October, 2002 EIR Altasciences Preclinical Seattle, LLC - EIR, 2002-10-11
August, 2002 FDA 483 Response WCG IRB, Inc - Form 483R, 2002-09-19
May, 2003 EIR James Yanney, DDS, MD - EIR, 2003-05-07
August, 2004 EIR BASi Northwest Laboratory - EIR, 2004-08-04
February, 2000 EIR Jonathan Jahr, MD - EIR, 2000-02-03
September, 2002 EIR Pacific University Institutional Review Board - EIR, 2002-09-05
October, 2000 FDA 483 Response Airgas USA, LLC - Form 483R, 2000-11-11
September, 2003 FDA 483 Rexim SA - Form 483, 2003-09-18
March, 2000 EIR Botanical Laboratories Inc - EIR, 2000-03-10
September, 2003 EIR Astra Zeneca - EIR, 2003-10-24
March, 2001 EIR Cynthia Clinkingbeard, MD - EIR, 2001-03-22
September, 2002 FDA 483 Pacific University Institutional Review Board - Form 483, 2002-09-05
June, 2000 EIR Knopp, Robert H., M.D. - EIR, 2000-06-28
March, 2002 FDA 483 Response Peter D. Londborg, MD dba Seattle Clinical Research Center - Form 483R, 2004-12-10
September, 2000 FDA 483 Northwest Clinical Research Center - Form 483, 2000-09-18
November, 2003 FDA 483 Response Biodevelopment Associates, Llc - Form 483R, 2004-02-24
April, 2001 EIR Nicholas W. Telew, MD - EIR, 2001-04-26
September, 2000 EIR Arifulla Khan MD - EIR, 2000-09-18
December, 2004 EIR Beal G. Essink, MD - EIR, 2004-12-13
April, 2000 EIR Klaff, Leslie J MD PhD - EIR, 2000-04-18
March, 2000 FDA 483 Response Botanical Laboratories Inc - Form 483R, 2000-05-16
December, 2004 FDA 483 Beal G. Essink, MD - Form 483, 2004-12-13
April, 2003 FDA 483 Response MDS Pharma Services - Form 483R, 2003-05-08
September, 2003 FDA 483 Response Swedish Orphan Biovitrum International AB - Form 483R, 2003-10-17
April, 2000 FDA 483 Response Klaff, Leslie J MD PhD - Form 483R, 2000-04-18
January, 2002 EIR Cynthia Clinkingbeard, MD - EIR, 2002-01-25
September, 2003 FDA 483 Swedish Orphan Biovitrum International AB - Form 483, 2003-09-29
January, 2004 FDA 483 Veterans Affairs Puget Sound Health Systems - Form 483, 2004-01-13
September, 2001 FDA 483 University of Washington Medical Center - Form 483, 2001-09-28
February, 2002 EIR Sanofi-Synthelabo - EIR, 2002-02-21
November, 2004 EIR CTI Biopharma Corp - EIR, 2004-11-12
April, 2003 EIR MDS Pharma Services - EIR, 2003-04-22
January, 2004 EIR Veterans Affairs Puget Sound Health Systems - EIR, 2004-01-13
August, 2001 EIR QLT Inc. - EIR, 2005-01-26
August, 2002 EIR WCG IRB, Inc - EIR, 2002-08-23
May, 2003 FDA 483 James Yanney, DDS, MD - Form 483, 2003-05-07
April, 2004 EIR Eli Lilly And Co. Limited - EIR, 2007-06-21
October, 2000 FDA 483 Respicare Home Respiratory and Medical - Form 483, 2000-10-26
March, 2001 FDA 483 Rhapsody Manufacturing Company - Form 483, 2001-03-15
June, 2000 FDA 483 Knopp, Robert H., M.D. - Form 483, 2000-06-28
February, 2002 FDA 483 Response Sanofi-Synthelabo - Form 483R, 2002-03-25
February, 2002 EIR Forest Laboratories Ireland Limited - EIR, 2002-02-06
June, 2002 EIR Wallace O'Farrell Marketing, Inc. - EIR, 2002-06-24
April, 2002 FDA 483 PhotoMedex, Inc. - Form 483, 2002-04-25
October, 2000 EIR Airgas USA, LLC - EIR, 2000-10-30
March, 2004 EIR Fred Hutchinson Research Center IRB - EIR, 2004-03-08
November, 2004 FDA 483 CTI Biopharma Corp - Form 483, 2004-11-12
September, 2002 FDA 483 Response Pacific University Institutional Review Board - Form 483R, 2002-09-27
April, 2001 FDA 483 Nicholas W. Telew, MD - Form 483, 2001-04-26
January, 2003 EIR Michael J. Kaempf, MD - EIR, 2003-01-10
June, 2002 EIR Air Products and Chemicals, Inc. - EIR, 2002-06-20
August, 2001 FDA 483 Virion, Inc - Form 483, 2001-08-22
June, 2001 EIR Dana C. Matthews, MD/PI - EIR, 2001-06-15
February, 2001 FDA 483 Bio-Safe Enterprises, Inc. - Form 483, 2001-02-26
April, 2003 FDA 483 MDS Pharma Services - Form 483, 2003-04-22
June, 2001 FDA 483 Dana C. Matthews, MD/PI - Form 483, 2001-06-15
November, 2003 EIR Biodevelopment Associates, Llc - EIR, 2003-11-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more